Elevated BCRP Transporter and Altered NF‐кB Pathway Mediate Zoledronic Acid Resistance in MCF‐7 Cells

Documenti analoghi

• In‐vitro Assessment of BCRP‐Mediated Efflux of Antiseizure Medications in Human Blood‐Brain Barrier Cell Model
  di: Shivangi Bora, et al.
  Pubblicazione: (2025)
• Growth Inhibition Activity Assessment of γ‐Lactam‐Containing Chemicals in Cultured MCF‐7 Cells and Xenografted Chick Embryos
  di: Chiao‐Yin Sun, et al.
  Pubblicazione: (2025)
• Evaluation of Side Effects and Efficacy of Ferromagnetic Alginate‐Chitosan Nanoparticles Encapsulating Docetaxel on PBMCs and MCF‐7 Breast Cancer Cells
  di: Robab Shekari Marand, et al.
  Pubblicazione: (2025)
• Biological Activities of Etodolac‐Based Hydrazone, Thiazolidinone and Triazole Derivatives on Breast Cancer Cell Lines MCF‐7 and MDA‐MB‐231
  di: Sevgi Kocyigit Sevinc, et al.
  Pubblicazione: (2025)
• A Newly Synthesized Benzimidazolium Salt: 1‐(2‐Cyanobenzyl)‐3‐(4‐Vinylbenzyl)‐1H‐Benzo[D]imidazol‐3‐ium Chloride as a Potential Anticancer Agent for Colon Cancer Treatment, In Vitro Study
  di: Nazmiye Bitgen, et al.
  Pubblicazione: (2025)